InvestorsHub Logo
Followers 104
Posts 16758
Boards Moderated 3
Alias Born 12/07/2005

Re: None

Tuesday, 02/14/2017 9:58:15 PM

Tuesday, February 14, 2017 9:58:15 PM

Post# of 4865
Gilead Announces 144-Week Data Evaluating Safety and Efficacy of Genvoya® for Treatment of HIV-1 in Treatment-Naïve Adults
http://www.gilead.com/news/press-releases/2017/2/gilead-announces-144week-data-evaluating-safety-and-efficacy-of-genvoya-for-treatment-of-hiv1-in-treatmentna%c3%afve-adults
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News